Guanying Wang

Guanying Wang currently serves as Medical Director at Abdera Therapeutics, having previously held the same role at Zai Lab and a Senior Manager position in Clinical Science at BeiGene. Experience includes work as a Clinical Scientist at Iovance Biotherapeutics, Inc., and leading data management for global Phase 2 clinical studies at Gilead Sciences. Early roles included an internship as a Medical Advisor at Kun Tuo (Quintiles China CRO), resident physician specializing in Rheumatology at Peking University People's Hospital, and research assistant roles focused on clinical protocols and biomarker identification. Educational qualifications include an MD in Internal Medicine and a Bachelor's degree in Economics from Peking University, alongside a Master of Science in Epidemiology and Clinical Research from Stanford University School of Medicine.